This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Mariko Furukawa: Innovator in Pharmaceutical Chemistry
Introduction
Mariko Furukawa is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. Her work has led to the filing of multiple patents, showcasing her innovative approach to drug discovery.
Latest Patents
Mariko Furukawa holds 2 patents related to Tetrahydroquinoline derivatives. These patents describe a novel compound with the formula (I), which includes various substituents such as alkoxycarbonyl, alkyl, and optionally substituted heterocyclic groups. The compounds exhibit inhibitory activity against cholesteryl ester transfer protein (CETP), making them valuable in the treatment of related health conditions.
Career Highlights
Furukawa is currently employed at Mitsubishi Tanabe Pharma Corporation, where she continues to advance her research in pharmaceutical innovations. Her work is characterized by a commitment to developing effective therapeutic agents that can improve patient outcomes.
Collaborations
Throughout her career, Mariko has collaborated with esteemed colleagues, including Hitoshi Kubota and Masakatsu Sugahara. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mariko Furukawa's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her ongoing work promises to impact the future of drug development significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
